B. Riley Wealth Advisors Inc. Has $256,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

B. Riley Wealth Advisors Inc. reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 76.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,157 shares of the pharmacy operator’s stock after selling 67,746 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $256,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Atlas Brown Inc. boosted its holdings in shares of Walgreens Boots Alliance by 1.8% during the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock worth $685,000 after purchasing an additional 550 shares during the period. Shilanski & Associates Inc. raised its stake in shares of Walgreens Boots Alliance by 5.3% during the 1st quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock worth $256,000 after purchasing an additional 591 shares in the last quarter. First Trust Direct Indexing L.P. lifted its holdings in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock valued at $696,000 after buying an additional 597 shares during the last quarter. Buckley Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 2.1% in the 1st quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock valued at $810,000 after buying an additional 785 shares in the last quarter. Finally, FinTrust Capital Advisors LLC raised its position in Walgreens Boots Alliance by 60.4% during the first quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after acquiring an additional 802 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 2.4 %

Shares of WBA opened at $9.08 on Wednesday. The stock has a 50 day simple moving average of $9.67 and a 200-day simple moving average of $13.73. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The stock has a market cap of $7.84 billion, a PE ratio of -1.35, a PEG ratio of 0.99 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 1 year low of $8.22 and a 1 year high of $27.05.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Barclays lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 23rd. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday. Bank of America cut their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. UBS Group cut their price target on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a report on Wednesday, July 3rd. Finally, JPMorgan Chase & Co. dropped their target price on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $14.50.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.